IP Library Patent Application 13902376
Patent Application
App. No. 13/902,376

ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/902,376
Abstract

Antisense molecules capable of binding to a selected target site in the dystrophin gene to induce exon skipping are described.

Claims (3)

1 . (canceled)

2 . An isolated antisense oligonucleotide 20 to 50 nucleotides comprising at least 17 bases of the sequence CUG UUG CCU CCG GUU CUG AAG GUG (SEQ ID NO:192), or an equivalent oligonucleotide, wherein said oligonucleotide, or its equivalent, induces exon 53 skipping in the human dystrophin pre-mRNA, and wherein the oligonucleotide comprises a modification, said modification comprising a base substitution of U by T.

3 . An isolated antisense oligonucleotide of 24-50 nucleotides in length, said oligonucleotide comprising a sequence which is complementary to a target nucleic acid sequence of the human exon 53 pre-mRNA, wherein said target nucleic acid sequence comprises a 24 nucleotide sequence that is complementary to the sequence CUG UUG CCU CCG GUU CUG AAG GUG (SEQ ID NO:192), and wherein the oligonucleotide comprises a modification, said modification comprising a base substitution of U by T.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 13, 2013
From: WILTON, STEPHEN DONALD; FLETCHER, SUE; MCCLOREY, GRAHAM
To: THE UNIVERSITY OF WESTERN AUSTRALIA
Reel/Frame 031201/0217 →